{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:52:39Z","timestamp":1792511559599,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.idnow.2025.105204","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:51:13Z","timestamp":1764175873000},"page":"105204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S","title":["Guidelines for Lyme borreliosis: treatment"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5003-540X","authenticated-orcid":false,"given":"A.","family":"Raffetin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Roblot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0501-5212","authenticated-orcid":false,"given":"C.","family":"Lenormand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2118-7751","authenticated-orcid":false,"given":"E.","family":"Baux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nguala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tattevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sobas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Yssel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3029-759X","authenticated-orcid":false,"given":"P.","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bouiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idnow.2025.105204_b0005","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 [Internet]. 2022. Guide du parcours de soins \u2013 Patients pr\u00e9sentant une suspicion de borr\u00e9liose de Lyme [cited September 11, 2025]. Available from: https:\/\/www.has-sante.fr\/jcms\/p_3323862\/fr\/guide-du-parcours-de-soins-de-patients-presentant-une-suspicion-de-borreliose-de-lyme."},{"issue":"6","key":"10.1016\/j.idnow.2025.105204_b0010","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-136-6-200203190-00005","article-title":"Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans","volume":"136","author":"Smith","year":"2002","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.idnow.2025.105204_b0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s150100050069","article-title":"Comparison of azithromycin and doxycycline in the treatment of erythema migrans","volume":"28","author":"Barsic","year":"2000","journal-title":"Infection"},{"key":"10.1016\/j.idnow.2025.105204_b0020","unstructured":"Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise, Coll\u00e8ge des universitaires de maladies infectieuses et tropicales, Soci\u00e9t\u00e9 fran\u00e7aise de dermatologie, Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie, Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne [Internet]. 2006. Borr\u00e9liose de Lyme : d\u00e9marches diagnostiques, th\u00e9rapeutiques et pr\u00e9ventives. 16eme conf\u00e9rence de consensus en therapeutique anti-infectieuse [cited September 11, 2025]. Available from: http:\/\/www.chru-strasbourg.fr\/sites\/default\/files\/documents\/2006-conf_consensus_lyme_texte_court.pdf."},{"key":"10.1016\/j.idnow.2025.105204_b0025","unstructured":"ESCMID Study Group for Lyme Borreliosis, European Concerted Action on Lyme Borreliosis [Internet]. 2013. Tick tests for the detection of Borrelia are not recommended by the ESCMID study group for Lyme borreliosis (ESGBOR) [cited September 11, 2025]. Available from: https:\/\/www.escmid.org\/fileadmin\/src\/media\/PDFs\/3Research_Projects\/ESGBOR\/Tick_tests_discouragement_ESGBOR2013.pdf."},{"issue":"3","key":"10.1016\/j.idnow.2025.105204_b0030","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1473-3099(16)30529-1","article-title":"Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial","volume":"17","author":"Schwameis","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.idnow.2025.105204_b0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM200107123450201","article-title":"Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite","volume":"345","author":"Nadelman","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.idnow.2025.105204_b0040","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jinf.2020.06.032","article-title":"A single dose of doxycycline after an Ixodes ricinus tick bite to prevent Lyme borreliosis: an open-label randomized controlled trial","volume":"82","author":"Harms","year":"2021","journal-title":"J Infect"},{"issue":"7\u20138","key":"10.1016\/j.idnow.2025.105204_b0045","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.medmal.2006.01.028","article-title":"Microbiological andpharmacological data useful forthetreatment ofLyme disease. Treatment andfollow up ofearly Lyme disease (erythema migrans)","volume":"37","author":"Martinot","year":"2007","journal-title":"Med Mal Infect"},{"issue":"3","key":"10.1016\/j.idnow.2025.105204_b0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/cid\/cis402","article-title":"Treatment of erythema migrans with doxycycline for 10 days versus 15 days","volume":"55","author":"Stupica","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idnow.2025.105204_b0055","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/jac\/dkx534","article-title":"Oral doxycycline versus intravenous ceftriaxone for treatment of multiple erythema migrans: an open-label alternate-treatment observational trial","volume":"73","author":"Stupica","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.idnow.2025.105204_b0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1473-3099(22)00528-X","article-title":"Treatment of erythema migrans with doxycycline for 7 days versus 14 days in Slovenia: a randomised open-label non-inferiority trial","volume":"23","author":"Stupica","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.idnow.2025.105204_b0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.medmal.2019.05.001","article-title":"Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosis","volume":"49","author":"Jaulhac","year":"2019","journal-title":"Med Mal Infect"},{"issue":"6","key":"10.1016\/j.idnow.2025.105204_b0070","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijantimicag.2005.02.007","article-title":"Susceptibility of Borrelia afzelii strains to antimicrobial agents","volume":"25","author":"Ruzic-Sabljic","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.idnow.2025.105204_b0075","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ijantimicag.2012.11.016","article-title":"In vitro susceptibility of European human Borrelia burgdorferi sensu stricto strains to antimicrobial agents","volume":"41","author":"Veinovi\u0107","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"7\u20138","key":"10.1016\/j.idnow.2025.105204_b0080","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.medmal.2009.02.038","article-title":"Pharmacodynamics of antibiotics in CSF: principles and consequences (predictive factors of efficacy)","volume":"39","author":"Van Bambeke","year":"2009","journal-title":"Med Mal Infect"},{"issue":"1","key":"10.1016\/j.idnow.2025.105204_b0085","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-061350","article-title":"Antibiotic exposure and dental health: a systematic review","volume":"152","author":"Ravindra","year":"2023","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.idnow.2025.105204_b0090","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/INF.0000000000002453","article-title":"Is doxycycline appropriate for routine treatment of young children with erythema migrans?","volume":"38","author":"Wormser","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.idnow.2025.105204_b0095","unstructured":"Centre de r\u00e9f\u00e9rence sur les agents T\u00e9ratog\u00e8nes (CRAT) [Internet]. 2024. Doxycycline \u2013 Grossesse [cited September 11, 2025]. Available from: https:\/\/www.lecrat.fr\/6396\/."},{"key":"10.1016\/j.idnow.2025.105204_b0100","unstructured":"National Institute of Child Health and Human Development [Internet] 2006- Drugs and Lactation Database (LactMed\u00ae) 2006-. Doxycycline. [Updated May 15, 2024; cited September 11, 2025]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK500561\/."},{"issue":"11","key":"10.1016\/j.idnow.2025.105204_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207067","article-title":"A systematic review on the impact of gestational Lyme disease in humans on the fetus and newborn","volume":"13","author":"Waddell","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.idnow.2025.105204_b0110","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s15010-025-02501-3","article-title":"Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis","volume":"53","author":"Raffetin","year":"2025","journal-title":"Infection"},{"issue":"9","key":"10.1016\/j.idnow.2025.105204_b0115","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","article-title":"Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"Wormser","year":"2003","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.idnow.2025.105204_b0120","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3390\/pathogens10080972","article-title":"Methodological quality assessment with the agree ii scale and a comparison of european and american guidelines for the treatment of lyme borreliosis: a systematic review","volume":"10","author":"Nguala","year":"2021","journal-title":"Pathogens"},{"issue":"9","key":"10.1016\/j.idnow.2025.105204_b0125","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jamadermatol.2018.2306","article-title":"Comparison of clinical course and treatment outcome for patients with early disseminated or early localized lyme borreliosis","volume":"154","author":"Stupica","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"7","key":"10.1016\/j.idnow.2025.105204_b0130","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/cid\/ciw417","article-title":"Borrelial lymphocytoma in adult patients","volume":"63","author":"Maraspin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2025.105204_b0135","first-page":"Doc14","article-title":"Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society. German","volume":"15","author":"Hofmann","year":"2017","journal-title":"Med Sci"},{"issue":"1","key":"10.1016\/j.idnow.2025.105204_b0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01780666","article-title":"Success and failure in the treatment of acrodermatitis chronica atrophicans","volume":"24","author":"Aberer","year":"1996","journal-title":"Infection"},{"issue":"45","key":"10.1016\/j.idnow.2025.105204_b0145","first-page":"751","article-title":"Lyme neuroborreliosis","volume":"115","author":"Rauer","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.idnow.2025.105204_b0150","doi-asserted-by":"crossref","unstructured":"European Study Group for Lyme borreliosis (ESGBOR), European Society of Clinical Microbiology and Infectious Disease, Dessau RB, van Dam AP, Fingerle V, Gray J, et al. To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis. Clin Microbiol Infect. 2018;24(2):118-24. doi: 10.1016\/j.cmi.2017.08.025.","DOI":"10.1016\/j.cmi.2017.08.025"},{"key":"10.1016\/j.idnow.2025.105204_b0155","unstructured":"National Institute for Health and Care Excellence [Internet]. 2018. Lyme disease [cited September 11, 2025]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng95\/resources\/lyme-disease-pdf-1837756839877."},{"key":"10.1016\/j.idnow.2025.105204_b0160","doi-asserted-by":"crossref","unstructured":"European Federation of Neurology Societies, Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 17(1) (2010) 8-16. doi: 10.1111\/j.1468-1331.2009.02862.x.","DOI":"10.1111\/j.1468-1331.2009.02862.x"},{"key":"10.1016\/j.idnow.2025.105204_b0165","unstructured":"Soci\u00e9t\u00e9 belge d'infectiologie et de microbiologie clinique [Internet]. 2016. Borr\u00e9liose de Lyme (infection \u00e0 Borrelia) [cited September 11, 2025]. Available from: http:\/\/organesdeconcertation.sante.belgique.be\/sites\/default\/files\/documents\/guide-lyme_borreliose_fr_2016_16dec.pdf."},{"issue":"9","key":"10.1016\/j.idnow.2025.105204_b0170","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/ene.12744","article-title":"Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis - a systematic review","volume":"22","author":"Dersch","year":"2015","journal-title":"Eur J Neurol"},{"issue":"11","key":"10.1016\/j.idnow.2025.105204_b0175","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1136\/jnnp-2022-329724","article-title":"Six versus 2 weeks treatment with doxycycline in European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blinded, randomised and placebo-controlled trial","volume":"93","author":"Solheim","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.idnow.2025.105204_b0180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0404.2012.01690.x","article-title":"Risk factors for a non-favorable outcome after treated European neuroborreliosis","volume":"127","author":"Eikeland","year":"2013","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"10.1016\/j.idnow.2025.105204_b0185","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/cid\/ciab370","article-title":"Adjunctive corticosteroids for lyme neuroborreliosis peripheral facial palsy-a prospective study with historical controls","volume":"73","author":"Avellan","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idnow.2025.105204_b0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00415-015-7923-0","article-title":"Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review","volume":"263","author":"Dersch","year":"2016","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.idnow.2025.105204_b0195","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cid\/ciw299","article-title":"Course and outcome of early european lyme neuroborreliosis (Bannwarth Syndrome): clinical and laboratory findings","volume":"63","author":"Ogrinc","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idnow.2025.105204_b0200","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1111\/ene.14962","article-title":"Clinical manifestations and long-term outcome of early Lyme neuroborreliosis according to the European Federation of Neurological Societies diagnostic criteria (definite versus possible) in central Europe. A retrospective cohort study","volume":"28","author":"Stupica","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.idnow.2025.105204_b0205","article-title":"Long term survival, health, social functioning, and education in patients with European Lyme neuroborreliosis: nationwide population based cohort study","volume":"361","author":"Obel","year":"2018","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.idnow.2025.105204_b0210","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1055\/s-0033-1349724","article-title":"Neuropsychological profile of children after an episode of neuroborreliosis","volume":"44","author":"Zotter","year":"2013","journal-title":"Neuropediatrics"},{"issue":"2","key":"10.1016\/j.idnow.2025.105204_b0215","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.idc.2015.02.004","article-title":"Diagnosis and treatment of Lyme arthritis","volume":"29","author":"Arvikar","year":"2015","journal-title":"Infect Dis Clin North Am"},{"issue":"12","key":"10.1016\/j.idnow.2025.105204_b0220","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/acr.22086","article-title":"Lyme arthritis: a comparison of presentation, synovial fluid analysis, and treatment course in children and adults","volume":"65","author":"Daikh","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.idnow.2025.105204_b0225","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1297-319X(03)00160-X","article-title":"Good outcomes of Lyme arthritis in 24 patients in an endemic area of Switzerland","volume":"71","author":"Renaud","year":"2004","journal-title":"Joint Bone Spine"},{"issue":"5","key":"10.1016\/j.idnow.2025.105204_b0230","first-page":"296","article-title":"Lyme borreliosis and other tick-borne diseases","volume":"49","author":"Gocko","year":"2019","journal-title":"Guidelines from the French Scientific Societies Med Mal Infect"},{"key":"10.1016\/j.idnow.2025.105204_b0235","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 [Internet] 2018. Borr\u00e9liose de Lyme et autres maladies vectorielles \u00e0 tiques [cited September 11, 2025]. Available from: https:\/\/www.has-sante.fr\/jcms\/c_2857558\/fr\/borreliose-de-lyme-et-autres-maladies-vectorielles-a-tiques."},{"issue":"6","key":"10.1016\/j.idnow.2025.105204_b0240","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.1780370616","article-title":"Treatment of Lyme arthritis","volume":"37","author":"Steere","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.idnow.2025.105204_b0245","first-page":"98","article-title":"Long-term results in patients with Lyme arthritis following treatment with ceftriaxone","volume":"24","author":"Valesova","year":"1996","journal-title":"Infection"},{"issue":"7\u20138","key":"10.1016\/j.idnow.2025.105204_b0250","first-page":"473","article-title":"Non antibiotic treatments ofLyme borreliosis","volume":"37","author":"Puechal","year":"2007","journal-title":"Med Mal Infect"},{"issue":"6","key":"10.1016\/j.idnow.2025.105204_b0255","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.semarthrit.2018.09.007","article-title":"Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis","volume":"48","author":"Grillon","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.idnow.2025.105204_b0260","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1463-5224.2005.00422.x","article-title":"Ocular penetration of oral doxycycline in the horse","volume":"8","author":"Gilmour","year":"2005","journal-title":"Veterinary Ophthalmol"},{"issue":"2","key":"10.1016\/j.idnow.2025.105204_b0265","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2460\/ajvr.67.2.310","article-title":"Pharmacokinetics and tissue distribution of doxycycline after oral administration of single and multiple doses in horses","volume":"67","author":"Davis","year":"2006","journal-title":"Am J Veterinary Res"},{"issue":"3","key":"10.1016\/j.idnow.2025.105204_b0270","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00414847","article-title":"Penetration of ocular compartments by tetracyclines. II. An experimental study with doxycycline. Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie","volume":"204","author":"Salminen","year":"1977","journal-title":"Albrecht von Graefe's Arch Klin Experiment Ophthalmol"},{"issue":"2","key":"10.1016\/j.idnow.2025.105204_b0275","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000521307","article-title":"Borrelia ocular infection: a case report and a systematic review of published cases","volume":"65","author":"Lindstr\u00f6m","year":"2022","journal-title":"Ophthalmic Res"},{"issue":"3","key":"10.1016\/j.idnow.2025.105204_b0280","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40123-020-00270-w","article-title":"The role of systemic antimicrobials in the treatment of endophthalmitis: a review and an international perspective","volume":"9","author":"Grzybowski","year":"2020","journal-title":"Ophthalmol Ther"},{"issue":"5","key":"10.1016\/j.idnow.2025.105204_b0285","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ophtha.2003.08.032","article-title":"Orbital myositis associated with Borrelia burgdorferi (Lyme disease) infection","volume":"111","author":"Carvounis","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.idnow.2025.105204_b0290","article-title":"Two cases of orbital myositis as a rare feature of lyme borreliosis","volume":"2011","author":"Sauer","year":"2011","journal-title":"Case Rep Infect Dis"},{"issue":"1","key":"10.1016\/j.idnow.2025.105204_b0295","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jfo.2011.03.015","article-title":"Les manifestations ophtalmologiques de la maladie de Lyme chez l'enfant: description de cinq cas et revue de la litt\u00e9rature","volume":"35","author":"Sauer","year":"2012","journal-title":"J Fr Ophtalmologie"},{"issue":"5","key":"10.1016\/j.idnow.2025.105204_b0300","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1177\/1120672119856943","article-title":"Lyme-associated uveitis: clinical spectrum and review of literature","volume":"30","author":"Bernard","year":"2020","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.idnow.2025.105204_b0305","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-93-1-8","article-title":"Lyme carditis: cardiac abnormalities of Lyme disease","volume":"93","author":"Steere","year":"1980","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.idnow.2025.105204_b0310","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/cid\/ciu411","article-title":"Third-degree heart block associated with lyme carditis: review of published cases","volume":"59","author":"Forrester","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idnow.2025.105204_b0315","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jacc.2018.11.035","article-title":"Diagnosis and treatment of lyme carditis: JACC review topic of the week","volume":"73","author":"Yeung","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.idnow.2025.105204_b0320","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7326\/0003-4819-110-5-339","article-title":"Lyme carditis: an important cause of reversible heart block","volume":"110","author":"McAlister","year":"1989","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.idnow.2025.105204_b0325","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1161\/CIRCULATIONAHA.112.101485","article-title":"Lyme disease and the heart","volume":"127","author":"Krause","year":"2013","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.idnow.2025.105204_b0330","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab140","article-title":"Lyme carditis in hospitalized children and adults, a case series","volume":"8","author":"Shen","year":"2021","journal-title":"Open Forum Infect Dis"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991925001836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991925001836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:55:01Z","timestamp":1765828501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991925001836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2666991925001836"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2025.105204","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines for Lyme borreliosis: treatment","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2025.105204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105204"}}